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Abstract 
One hundred percent fruit juice (FJ) contains bioactive compounds with antioxidant activity. As such, this fruit form has 
the potential to improve antioxidant status and mediate outcomes influenced by redox status. A systematic review of the 
literature published between 1995-2013 was conducted using PubMed database to evaluate associations between intake of 
100% FJ and markers of antioxidant/oxidant status and blood lipid levels in healthy, free-living adults > 18 years. Data 
extraction and analysis was conducted according to the Academy of Nutrition and Dietetics Evidence Analysis Process. 
Limited evidence from ten clinical trials meeting inclusion/exclusion criteria suggests potential improvements in a variety 
of antioxidant or oxidants biomarkers post-consumption of 100% FJ. Weak evidence from five studies suggests that one or 
more blood lipid measures may be positively influenced by consumption of 100% FJ. Heterogeneity in study methodology 
including biomarkers, 100% FJ type, dosage, and intervention duration precludes the ability to make evidence-based 
recommendations regarding a specific dose-duration-juice effect. Key characteristics in study designs were identified 
which must either be controlled or statistically adjusted for in future investigations in order to obtain a more accurate 
understanding of the complex relationship between metabolic outcomes and consumption of 100% FJ in context of a 
healthy dietary pattern. 
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ABSTRACT 
 
One hundred percent fruit juice (FJ) contains bioactive compounds with antioxidant activity. As 
such, this fruit form has the potential to improve antioxidant status and mediate outcomes 
influenced by redox status. A systematic review of the literature published between 1995-2013 
was conducted using PubMed database to evaluate associations between intake of 100% FJ and 
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markers of antioxidant/oxidant status and blood lipid levels in healthy, free-living adults > 18 
years. Data extraction and analysis was conducted according to the Academy of Nutrition and 
Dietetics Evidence Analysis Process. Limited evidence from ten clinical trials meeting 
inclusion/exclusion criteria suggests potential improvements in a variety of antioxidant or 
oxidants biomarkers post-consumption of 100% FJ. Weak evidence from five studies suggests 
that one or more blood lipid measures may be positively influenced by consumption of 100% FJ. 
Heterogeneity in study methodology including biomarkers, 100% FJ type, dosage, and 
intervention duration precludes the ability to make evidence-based recommendations regarding a 
specific dose-duration-juice effect. Key characteristics in study designs were identified which 
must either be controlled or statistically adjusted for in future investigations in order to obtain a 
more accurate understanding of the complex relationship between metabolic outcomes and 
consumption of 100% FJ in context of a healthy dietary pattern. 
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INTRODUCTION 
 
Fruit contains numerous bioactive compounds including vitamins and phytochemicals with well- 
characterized antioxidant activity. Upon processing to its liquid serving form, 100% fruit juice 
(FJ) has been shown to retain an abundance of these antioxidants (Ruxston et al., 2006; Crowe 
and Murray, 2013). Thus, 100% FJ, a serving equivalent to whole fruit according to the Dietary 
Guidelines for Americans 2010, represents a functional food with the potential to positively 
impact metabolic outcomes mediated by antioxidant activity (United States Department of 
Agriculture and United States Department of Health and Human Services, 2010). Given the 
potential benefit to be derived from 100% FJ consumption in context of a diet guided by the 
Dietary Guidelines, the aim of this systematic review was to examine evidence on the association 
and impact of 100% FJ intake on antioxidant and oxidant status and blood lipid profiles among 
adults. 
Multiplicity of Measures and Modifiers 
 
Evidence suggests that oxidative stress is important in the initiation and pathogenesis of chronic 
diseases including cardiovascular disease, diabetes, dyslipidemia, and cancer among others 
(Higashi et al., 2009). Mechanistically, the bioactive compounds within 100% FJ may contribute 
antioxidant action and decrease oxidative stress in the body (Collins, 2005; Da Costa et al., 
2012). By shifting the redox balance to reduce oxidative stress, bioactive compounds with 
antioxidant activity may influence numerous health outcomes including blood lipid levels. More 
specifically, lipid profiles may be influenced by antioxidant effects on cholesterol metabolism 
and lipoprotein regulatory pathways in the liver by inhibiting the production of endogenous 
lipoproteins, inhibiting low-density lipoprotein cholesterol (LDL) oxidation, and reducing 
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platelet aggregation (Kurowska et al., 2000; Aptekmann and Cesar, 2010). Since elevated total 
cholesterol, LDL, and triglycerides along with decreases in high-density lipoprotein cholesterol 
(HDL) are major risk factors for atherosclerosis, 100% FJ may play a preventative role in 
delaying the progression of atherosclerotic plaque formation in arterial walls. In light of the 
prevalence of atherosclerosis and cardiovascular disease in Western societies, evaluation of 
foods with the potential to reduce these risks is warranted. 
Research evaluating the potential impact of 100% FJ on antioxidant and oxidant status employs a 
variety of outcome measures or biomarkers. Among the more common markers of antioxidant 
status are the ferric reducing ability of plasma (FRAP), oxygen radical absorbance capacity 
(ORAC) assay, and total peroxyl-radical trapping activity (TRAP). These assays allow for 
measuring the ability of antioxidants in a sample to quench a free radical exposed to that sample 
(Huang et al., 2005). These measures are referred to as a capacity measure or biomarker 
quantitating the strength of the cumulative antioxidants in the sample against the free radical 
generating oxidation. Unfortunately, since different radical species or initiators of oxidation are 
employed in the various methods, comparison of results across studies with differing 
methodologies is challenged. The question of biological relevance of these assays has been  
raised with particular emphasis on assay kinetics along with the fact that numerous free radicals 
are present in the body and these assays utilize only one radical source exposed to the biological 
sample in vitro. Although assay kinetics cannot exactly mimic biological conditions in vivo, 
these assays provide a capacity measure of antioxidant status which may be influenced by study 
treatment or intervention. 
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Much like the multiplicity in measurements of antioxidant status, numerous measures of 
oxidative stress are employed to assess a variety of oxidized end products including lipids, 
proteins, and DNA. Examples of such methodological assessments include thiobarbituric acid- 
reactive substances (TBARS) or LDL-oxidation for assessing lipid oxidation products, protein 
carbonyls for assessing protein oxidation, 8-hydroxydeoxyguanosine (8-OHdG) for assessing 
DNA oxidation, and reactive oxygen species (ROS) measurements for assessing circulating 
levels of oxidants in biosamples (Dalle-Donne et al., 2006; Giustarini et al., 2009). In many 
studies, multiple methods are used in order to comprehensively assess the spectrum of oxidizable 
substrates as outcomes in nutrition research. 
Complexity and Context 
 
It is well recognized that the background diet, lifestyle, and genetics along with environmental 
factors can restrict the ability to attribute metabolic effects solely to one food, beverage, or 
compound (Willet, 2012). In other words, ―the effect‖ of consumption of 100% FJ on antioxidant 
status or blood lipid profiles is highly contingent on a host of other factors. Additionally, while 
the effects of consumption of 100% FJ on antioxidant measures may be relatively immediate, the 
relationships between 100% FJ consumption and its effect on downstream measures like lipid 
profiles are likely to be highly confounded by factors such as individual variations in dietary and 
exercise patterns. Thus, the complexity of mechanisms and diversity of measures pose serious 
challenges to carrying out a systematic review—where the goal is typically to formulate a 
narrow, clearly defined question and seek a correspondingly simple answer. Acknowledging the 
heterogeneity in outcome measures of antioxidant/oxidant status and the resulting difficulty 
presented in cross-study comparison, the impetus for this systematic review of the literature 
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shifted from treating variations in methodology as a limitation in an attempt to find ―one best 
measure‖ of the effects of 100% FJ consumption to exploring heterogeneity among studies to 
discern patterns useful for future research. We do this first by categorizing the evidence more 
globally as providing evidence for or against potential improvements in antioxidant/oxidant 
status and blood lipid profiles following consumption of 100% FJ. Secondly, we seek to identify 
the range of confounders present in the research. By employing a global view of the evidence 
despite methodological differences and by identifying known confounders, strategies for future 
investigation may be developed that would allow for cross-study analyses and control of 
modifying factors innate to investigating this relationship. In turn, strategies for continuity in 
future investigations may allow for establishing evidence-based recommendations regarding a 
specific dose-duration-juice effect. 
METHODS 
 
Evidence Analysis Team and Process 
 
The workgroup included six registered dietitians or registered dietitian-nutritionists with 
clinical or research experience along with support of a methodologist/statistician. A 
trained and experienced project manager facilitated these meetings with the assistance of 
the lead analyst. A complete description of the Evidence Analysis Process is available at 
the Academy‘s Evidence Analysis Library (EAL) website (2014). 
Literature Search 
 
Studies were initially identified in PubMed and published in English between January 1995 and 
November 2013. The following syntax was used to identify relevant antioxidant and oxidant 
studies: 
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1. ―fruit juice‖ 
 
2. ―oxidant stress‖ or ―oxidative stress‖ 
 
3. ―antioxidant capacity‖ or ―anti-oxidant‖ 
 
4. ―lipid oxidation‖ or ―protein oxidation‖ 
5.   #2 or #3 or #4 
6.   #1 and #5 
 
A similar search was carried out to identify blood lipid outcomes. Title and abstracts of studies 
identified through the above search were reviewed by work group members and the analysis 
team. A list of relevant studies was identified for full text review based on work group 
consensus. Work group members then read all full text articles to determine whether inclusion 
criteria were met and to identify additional sources from study reference lists. A final list of 
relevant sources was identified by workgroup consensus with input from the analysis team. 
Application of Inclusion/Exclusion Criteria 
 
First and foremost, in order to include a study in this systematic review, the Food and Drug 
Administration‘s definition was used to provide the initial framework for determining if juices 
investigated in each study were 100% FJ. According to 21CFR101.30, ―juices directly expressed 
from a fruit or vegetable (i.e., not concentrated and reconstituted) shall be considered to be 100 
percent juice and shall be declared as 100 percent juice" (U.S. Food and Drug Administration 
Code of Federal Regulations, 2013). The above definition was expanded to include juices from 
concentrate which were reconstituted to the original concentration. Inclusion criteria included 
use of 100% FJ of a single or mixed type, healthy adults > 18 years of age, no preference as to 
study design, a minimum of 10 subjects per study group, drop-out rate under 20%, and at least 
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one marker of antioxidant or oxidant status or measure of lipid outcomes. Studies were excluded 
from review based on the following exclusion criteria: 100% FJ not specified, individuals less 
than 18 years of age, articles not published in peer-reviewed journals, and research presented on 
in abstract or presentation format only. For markers of antioxidant and oxidant status, exclusion 
criteria also included studies on endothelial function without markers of oxidative stress. This 
systematic search process identified 10 studies reporting on markers of antioxidant or oxidant 
status (Figure 1) and five studies reporting on blood lipid levels (Figure 2). 
Data Extraction and Analysis 
 
The work group, in consultation with the analysis team, developed the analytic framework for 
data extraction and the Academy‘s online Data Extraction Tool was used to extract and store 
data from the research articles. Trained analysts or methodology experts extracted the following 
data from each eligible research article: title, year and journal of publication, study design, 
intervention and control groups (if applicable), details of interventions (type of intervention, who 
delivered the intervention, duration of intervention, mode of intervention), confounders and 
effect mediators identified, and outcomes of interest (markers of antioxidant/oxidant status or 
blood lipid levels). Data extracted by one analyst were verified by a second analyst for accuracy. 
Risk of bias for each study was double assessed using the Academy‘s quality rating checklist in 
accordance with Institutes of Medicine standards (Eden, Levit, Berg, & Morton, 2011; Academy 
of Nutrition and Dietetics, 2014). An overall quality rating was assigned to each article based on 
assessment of specific checklist items (Appendix 1). Differences among analysts were resolved 
by consensus in consultation with the lead analyst and project methodologist. 
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Although data on mean change in target outcomes were extracted with sufficient detail for meta- 
analysis, it was determined that variation among studies precluded the ability to accurately 
estimate a pooled effect size. Thus, the focus shifted to identifying systematic patterns in the 
relationships between variations in study characteristics and reported outcomes. In order to 
facilitate this comparison, mean changes in antioxidant, oxidant and blood lipid measures were 
classified more generally into ―positive‖ versus ―negative or no‖ change from baseline to follow- 
up. Because of the likelihood of type 2 error in the smaller studies and the high sensitivity of 
outcomes to confounding, mediating, and contextual factors, direction of the effect and non- 
statistical significance was used to determine outcome classification. 
Development of Conclusion Statements 
 
Evidence summary and conclusion statements on the impact of 100% FJ consumption on 
diet and weight status of children were drafted by the workgroup and lead analyst based 
on evidence analysis after completion of the data extraction process. The EAL Manual 
for Grading the Strength of the Evidence (2014) was used for grading the conclusion 
statements according to the following grades: I (good/strong), II (fair), III (limited/weak), 
IV (expert opinion only), or V (grade not assignable). 
RELATIONSHIP BETWEEN INTAKE OF 100% FJ AND MARKERS OF 
ANTIOXIDANT AND OXIDANT STATUS 
Research Identified 
 
Ten clinical trials met the inclusion criteria for evaluating the impact of the 100% FJ 
consumption on markers of antioxidant status or oxidative stress in adults (Freedman et al., 2001; 
Bub et al., 2003; Gorinstein et al., 2004; Ko et al., 2005; Inoue et al., 2008; Ghanim et al., 2010; 
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Karlsen et al., 2010; Rowe et al., 2011; Snyder et al., 2011; Buscemi et al., 2012). Studies varied 
widely—not merely in the type and timing of the antioxidant and oxidant markers examined, but 
also in the types of juice or juice mixes examined, dose administered, subject characteristics and 
behavioral confounders. 
Effects of 100% FJ Consumption on Antioxidant Status 
 
Seven clinical trials evaluated the effects of 100% FJ consumption on markers of antioxidant 
status (Freedman et al., 2001; Bub et al., 2003; Gorinstein et al., 2004; Ko et al., 2005; Karlsen et 
al., 2010; Rowe et al., 2011; Snyder et al., 2011) (Table 1). Six of the seven studies reported 
post-consumption improvement in at least one measure of antioxidant status; four of which 
reached statistical significance (Freedman et al., 2001; Gorinstein et al., 2004; Ko et al., 2005; 
Snyder et al., 2011). Among these, two studies employed post-prandial designs (Ko et al., 2005; 
Snyder et al., 2011). According to Ko et al. (2005), an increase in antioxidant activity as 
determined by a reduction in relative dichlorofluorescein fluorescence (DCF) (P<0.05) was 
observed after 30, 60, 90 and 120 minutes among 10 males consuming 150 ml of eight different 
100% FJs (apple, orange, grape, peach, plum, kiwi, melon and watermelon) on separate days 
with a one-day washout period in between testing days. In another post-prandial study, Snyder et 
al. (2011) reported a significant increase in ORAC (P<0.05) in 16 healthy male and females after 
1 hour with a return to baseline by hour three following consumption of 591 ml of 100% orange 
juice with a high-carbohydrate breakfast. 
By lengthening the intervention and observation period, Freedman et al. (2001) reported a 
significant increase in antioxidant activity as measured by ORAC (0.6 ± 0.1 to 0.9 ± 0.1, P<0.05) 
following a two-week intervention in which 20 males and females consumed 7 ml/kg/day of 
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100% purple grape juice. By providing a lower FJ dose (100mL or 200mL 100% juice of 
pumelo-grapefruit hybrid) and for a longer period (30 days), Gorinstein et al. (2004) reported 
significant increases in serum antioxidant activity measured by the Trolox equivalent antioxidant 
coefficient (TEAC) assay in both treatment groups compared to the control group; furthermore, 
the serum antioxidant activity between the treatment groups was significantly different with 
reported increases compared to the control group of 16.9% among the 24 individuals consuming 
the 100mL dose and 33.1% higher among the 24 individuals consuming 200mL of 100% juice 
from the pumelo-grapefruit hybrid. 
Although Rowe et al. (2011) reported non-significant improvements in antioxidant capacity 
among subjects (n=40) ingesting 360mL of 100% grape juice for nine-weeks, ORAC scores 
increased by 41.1 umol Trolox equivalents (TE)/mL. In contrast, by the end of the study, serum 
ORAC decreased by 66.2 umol TE/mL in the placebo arm of this randomized, double-blind 
placebo-controlled parallel intervention. Although non-significant results were observed, the 
effect on trend suggests movement in the direction of increased antioxidant capacity influenced 
by 100% FJ consumption. In contrast, Bub et al. (2003) was the only study to report no 
improvement in antioxidant status. However, only one biomarker of antioxidant status (FRAP) 
was reported. The only other study to report on FRAP as an outcome measure of antioxidant 
status was Karlsen et al. (2010) who reported an improvement. The intervention juices differed 
between the two studies, and the intervention period (4 weeks) reported by Karlsen et al., (2010) 
was double that of the randomized crossover trial reported by Bub et al. (2003). Additionally, 
sample characteristics were quite different between the two studies. For example, Bub et al. 
(2003) evaluated an all-female sample with a mean age of 35±4 years which was nearly 20 years 
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younger than the sample population investigated by Karlsen et al. (2010) (53 years (range: 34 to 
68 years). While it is impossible to determine with any certainty, differential sensitivity of the 
FRAP assay compared to other antioxidant measures, type of juice, length of consumption or 
differences in study characteristics might all factor into explaining the inconsistency in between 
Bub et al. (2003) and findings of the other six studies examined. 
 
 
Despite the heterogeneity in juice types evaluated and antioxidant biomarkers employed, two of 
the identified studies allowed for cross-study comparison based on similarities in methodological 
approach to investigating the influence of 100% FJ consumption on antioxidant status (Freedman 
et al., 2001; Rowe et al., 2011). In both studies, 100% grape juice was evaluated and serum 
ORAC was the biomarker. While Rowe et al. (2011) reported non-significant increases in 
antioxidant capacity following consumption of 360mL of 100% grape juice for nine-weeks, 
Freedman et al. (2001) reported significant increases in antioxidant capacity post-intervention by 
testing a higher dosage (7mL/kg/d) and shorter effect time (two weeks). Comparison of results 
suggests a possible dose-response relationship warranting consideration in future investigations. 
Effects of 100% FJ Consumption on Oxidant Status 
Six studies reported on the impact of 100% FJ consumption and markers of oxidant status (Bub 
et al., 2003; Ko et al., 2005; Inoue et al., 2008; Ghanim et al., 2010; Snyder et al., 2011; Buscemi 
et al., 2012) (Table 1). All six reported post-consumption improvement in at least one measure of 
oxidant status, with four of these studies reporting statistically significant improvements in 
oxidative measures (Bub et al., 2003; Inoue et al., 2008; Ghanim et al., 2010; Snyder et al., 
2011). However, three of the four studies reporting statistically significant improvements did not 
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control for other dietary factors that may have influenced oxidative status (Inoue et al., 2008; 
Ghanim et al., 2010; Snyder et al., 2011). Thus, the effect of 100% FJ cannot be clearly isolated. 
Among those reporting significance, two employed post-prandial study designs (Ghanim et al., 
2010; Snyder et al., 2011). For example, Snyder et al. (2011) reported a significant increase 
(P<0.05) in serum lipoprotein oxidation lag time among 16 healthy male and females after 1, 2 
and 3 hours following consumption of 591 ml 100% orange juice with high-carbohydrate 
breakfast. Serum lipoprotein oxidation area under the curve was also lowered at the 2 and 3 hr. 
time points (P<0.05). Ghanim et al. (2010) reported a decrease in ROS (P<0.05) after 10 healthy 
males and females consumed 300 calories (approximately 720ml) of 100% orange juice with a 
900 kcal high-fat, high-carbohydrate meal as compared to consumption of the meal with water or 
a glucose drink, respectively. The decrease in ROS generation remained significant compared to 
the control up to three hours post-consumption. 
Among intervention studies of longer duration, Inoue et al. (2008) reported a 22% decrease in 
urinary 8-hydroxy-deoxyguanosine (U 8-OHdG) (P<0.05) and a 4% decrease in ROS (P<0.01) 
after 20 male smokers consumed 70 ml of 100% camu-camu juice for seven days. Following a 
two-week intervention period, Bub et al. (2003) reported a 13% reduction in TBARS, a measure 
of lipid peroxidation, (0.86 ± 0.3 to 0.75 ± 0.3µmol/L, P<0.05) among 14 males consuming 331 
ml of mixed-type 100% FJ. While oxidative findings in Karlsen et al. (2010) and Buscemi et al. 
(2012) did not reach statistical significance, the direction of the effect for at least one oxidant 
status measure was consistent with the findings reported above. 
Although improvements in a variety of biomarkers were observed post-consumption of 100% FJ, 
the evidence suggests that relationship is contingent on a range of factors, and thus, no simple 
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estimate of the effect is available. As such, the overall strength of the available evidence on the 
relationship between 100% FJ and antioxidant and oxidant status was scored as a Grade III 
(limited). 
RELATIONSHIP BETWEEN INTAKE OF 100% FJ AND BLOOD LIPID LEVELS 
 
Research Identified 
 
Five studies including three clinical trials (Aviram et al., 2000; Kurowska et al., 2000; Gorinstein 
et al., 2004) and two cross-sectional studies (Mattei et al., 2012; O‘Neil et al., 2012) met the 
inclusion criteria for review and evaluation (Table 2). Among the three intervention studies 
evaluating downstream effects of 100% fruit juice consumption on blood lipid levels (Aviram et 
al., 2000; Kurowska et al., 2000; Gorinstein et al., 2004), two of the three reported significant 
improvements in at least one blood lipid measure following intervention periods of > 28 days 
(Kurowska et al., 2000; Gorinstein et al., 2004). The lack of improvement reported by Aviram et 
al. (2000) may possibly be attributed to differences in the bioactive components of the juices 
examined or the small dose provided by Aviram et al. (2000) (50mL/d for a two-week period). 
This inference is supported by Kurowska et al. (2000) in which blood lipid improvements were 
visible only at the higher doses of 500 or 750 ml/day versus 250mL/d. 
According to Gorinstein et al. (2004), LDL levels were significantly decreased among adults in 
the intervention group (n=24) of a randomized controlled trial compared to the control group 
(n=24) following consumption of either 100ml/d or 200 ml/day of 100% pummelo-grapefruit 
hybrid juice over a 30-day period (100ml/d treatment - 5.63±0.2 versus 6.37±0.2 mmol/L, P < 
0.01; 200ml/d treatment - 5.03±0.2 versus 6.37±0.2 mmol/L, P<0.0005, respectively). 
Additionally, following the 200 ml/day intervention, total cholesterol (-16%) and triglycerides (- 
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25%) were also significantly lowered. HDL was unaffected by either juice intervention dose. 
Study results should be interpreted with caution since the authors did not adjust for any 
confounders and no information was provided on the dietary intake of subjects, including other 
types of 100% FJ consumed. 
In contrast to significant improvements in blood lipid levels reported by Gorinstein et al. (2004) 
at doses < 200ml/d of 100% citrus juice (pumelo-grapefruit hybrid), Kurowska et al. (2000) 
reported no significant improvements in lipid levels among adults (n=25) following consumption 
of a similar dose (250ml/day) of 100% orange juice for four-weeks. However, when the dose 
was increased to 750ml/d, a 21% increase (P< 0.001) in HDL was observed after four-weeks 
along with a significant increase in plasma triglycerides (P = 0.02) by 30%. Caution in 
interpreting the positive and negative results is warranted as subjects recruited had moderately 
elevated blood lipid levels and were instructed to follow the American Heart Association Step I 
cholesterol-lowering diet before and during the intervention. Furthermore, it should be noted that 
750 ml (3 cups) of 100% orange juice is an unrealistic amount to consume on a daily basis, and it 
exceeds the recommendation for fruit for virtually all energy patterns (United States Department 
of Agriculture and United States Department of Health and Human Services, 2010). 
Among the two cross-sectional studies meeting the inclusion/exclusion criteria, O‘Neil et al. 
(2012) reported that consumers of 100% orange juice exhibited significantly lower (P = 0.022; 
3.2 mg/dL) total cholesterol levels than non-consumers in a national, cross-sectional sample of 
the United States population (n=8,861). Additionally, consumers of 100% orange juice had 
significantly lower LDL than non-consumers (112.5±1.4 mg/dL versus 116.7±0.93 mg/dL; 
P=0.0110). While the study adjusted for a number of confounders, the method of dietary data 
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collection provides better estimates for populations than for individuals. Based on this study 
design, it cannot be inferred that drinking 100% FJ caused decreased total cholesterol in 
individuals or that this difference is, in fact, due exclusively to 100% FJ consumption. In a 
similar study design, Mattei et al. (2012) reported statistically higher HDL levels among adults 
(n=254) consuming one or more servings of fresh-squeezed 100% FJ compared to non- 
consumers (n=811) (mean 1.1±0.01mmol/L for daily consumers versus 1.07±0.01mmol/L for 
non-consumers, P-trend = 0.033). This observational study used a food frequency questionnaire 
(FFQ) to assess the frequency of ‗homemade‘ FJ intake comprised of 100% juice from freshly 
squeezed fruit only. Although a number of factors were adjusted for, it is unknown if the FFQ 
was validated; furthermore, it should be acknowledged that this measurement relies on self- 
reporting of dietary intake and composition of juice consumed. 
Taken together, there is weak evidence to suggest that one or more blood lipid measures may be 
positively influenced or associated with consumption of 100% FJ in amounts exceeding 100mL, 
but this relationship is highly contingent on many factors. As such, the overall strength of the 
available evidence was scored as a Grade III (limited). 
DISCUSSION 
 
Acknowledging the heterogeneity of the evidence reviewed, two questions emerge: (1) what is 
discernible from the data based on both the significance and trend for effect and (2) how do we 
better investigate this relationship in order to establish evidence-based guidelines? To answer the 
first question, key characteristics of study designs must either be controlled or statistically 
adjusted for in order to obtain a more accurate understanding of the influence of 100% FJ on 
metabolic outcomes. Table 3 presents a breakdown of characteristics that were found to 
 
ACCEPTED MANUSCRIPT 
18 ACCEPTED MANUSCRIPT 
 
 
 
 
influence antioxidant/oxidant status or blood lipid levels in the evidence reviewed. Recognizing 
that the most basic difference between studies is the type of 100% FJ evaluated, it must be 
acknowledged that significant differences exist in the antioxidant, phenolic, and flavonoid 
content of various types of 100% FJ (Crowe and Murray, 2013). Thus, differences in antioxidant 
capacity would be expected to influence their ability to impact metabolic outcomes. Beyond this 
primary difference, other differences among study designs and findings suggest that subject 
characteristics and behaviors are implicated in the relationships between 100% FJ intake and 
physiological outcomes. In short, the evidence examined in this systematic review indicates that 
these study design and sample characteristics are implicated in preventing accurate estimates of 
the immediate effects of consuming 100% FJ on antioxidant and oxidant status as well as the 
downstream and more highly mediated effects on blood lipid profiles. Nevertheless, evidence 
based on trend and significance of effect is largely consistent in direction and suggest that 
bioactive compounds within 100% FJ have the potential to mechanistically influence antioxidant 
and oxidant status as well as downstream events mediated by redox balance. 
The potential role of 100% FJ in human health and disease prevention is widely acknowledged 
(Hyson, 2015), yet given the sensitivity of outcomes to multiple factors, evaluating the 
relationship between consuming 100% FJ and target outcomes is not merely complicated, but 
complex (Wong, 2013). Adding to the complexity is the fact that the studies identified and 
evaluated were generally of neutral quality for answering the questions, due largely to potential 
bias introduced by study participant selection which may influence redox threshold, metabolism 
of FJ, etc. Assessment of quality criteria by study is presented in Appendix 1. Taken collectively, 
the complexity of the question does not allow for a simple answer. As such, the second lesson 
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learned from evaluating the research is that the important question to ask may not be ―what is the 
relationship between 100% FJ intake and antioxidant and oxidant status or lipid measures‖, but 
rather ―under what conditions (e.g., baseline health status, typical diet pattern) is consumption of 
100% FJ (type of juice, dosage, consumption pattern, etc.) associated with these measures or 
outcomes, at what time period, and for whom (sex, age, genetic profile, etc.)‖. Figure 3 presents 
a schematic illustration of the study and subject characteristics that must be taken into account in 
order to obtain a clearer picture of these relationships. 
In order to answer this question, well-designed and adequately powered clinical trials evaluating 
standardized doses of 100% FJ are warranted. Since eight ounces of 100% FJ represents a 
serving equivalent to whole fruit, clinical evaluation of this serving size may be an appropriate 
starting dose for evaluating metabolic outcomes influenced by consumption. Furthermore, while 
multiple methodologies are available to assess antioxidant and oxidant status, a select battery of 
tests should be conducted in every study to allow for synthesis and comparison of cross-study 
results. All studies must adjust for potential confounders including background diet among 
others in order to establish evidence-based guidelines on 100% FJ as a functional food in context 
of a diet guided by the Dietary Guidelines for Americans 2010. 
CONCLUSIONS 
 
Despite the heterogeneity among studies, the evidence of benefit from consumption of 100% FJ 
exists such that 100% FJ may, under some conditions, have a positive impact on 
antioxidant/oxidant status and blood lipid levels. However, the ability to make evidence-based 
recommendations regarding a specific dose-duration-juice effect is limited until such time as key 
 
ACCEPTED MANUSCRIPT 
20 ACCEPTED MANUSCRIPT 
 
 
 
 
characteristics in study designs are controlled or statistically adjusted for in order to more 
accurately understand the influence of 100% FJ on metabolic outcomes. 
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Table 1 Studies on markers of antioxidant and oxidant status and consumption of 100% fruit 
juice among adults 
 
 
 
Author 
 
 
Groups 
 
 
100% Fruit 
Juice Type 
 
Antioxidant 
Outcomes1 
 
Oxidant Outcomes1 
Study 
Design 
 
Final N 
 Changes in 
Outcomes2 
Changes in Outcomes2 
 
 
 
Quality 
Rating 
 
 
 
 
Sex (% Female) 
 
 
 
 
Dose 
✚ improved 
significantly 
+ improved 
non- 
significantly 
 
✚ improved 
significantly 
+ improved non- 
significantly 
  
Age (mean±SD) 
Duration of 
Exposure 
 did not 
improve 
 
 did not improve 
Postprandial Studies    
Snyder et 
al. (2011) 
Group: Placebo, 
placebo + 
hesperidin, 
mixed 
 
Juice: orange 
Dose: 591ml 
Duration: one 
✚ ORAC: - 
(P<0.05) 
 
✚ Serum oxidation lag 
time (P<0.05) 
✚ Serum oxidation area 
Randomize 
d 
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Crossover 
Trial 
group, orange 
juice 
N: 16 
 
% Female: NR 
 
Age: 18 to 24 
years (range) 
serving  under the 
curve: (P<0.05) 
 
 
 
Negative 
 
Ghanim et 
al. (2010) 
Non- 
Randomize 
d 
Controlled 
Trial 
Neutral 
Groups: HFHC + 
water, HFHC + 
glucose, HFHC + 
OJ 
N: 10 
 
% Female: NR 
 
Age: 20 to 40 
years (range) 
 
 
 
Juice: orange 
 
Dose: 300 
calories 
Duration: five 
hours 
  
 
 
 
 
Treatment x time 
interaction 
✚ ROS-PMN (P<0.05) 
 
✚ ROS-MNC (P<0.05) 
Ko et al. 
(2005) 
Group: Treatmen 
t 
N: 10 
Juice: apple, 
orange, peach, 
kiwi, plum, 
melon, 
 
✚ DCHF: All 
juices (P<0.0 
5) except 
 
Non- 
Randomize 
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d 
Crossover 
Trial 
% Female: 0 
 
Age: 24±0.6 
 
years 
watermelon, 
grape, pear 
Dose: 150ml 
 
Duration: one 
serving 
pear: NS  
 
Neutral 
 
Longer Term Studies    
 
 
 
Bub et al. 
(2003) 
Randomize 
d 
Crossover 
Trial 
Neutral 
 
 
 
 
 
 
 
Group: Juice A 
N: 14 
% Female: 0 
 
Age: 35±4 years 
Juice: Juice 
blend A 
prepared with 
apple, orange, 
mango with 
aronia, blue- 
berries, and 
boysenberries 
Dose: 330ml/da 
y 
Duration: two 
weeks 
 
 
 
 
 
 
 
 
 
 
 
 FRAP 
 
Juice A 
 
 
 
 
 
 
 
+ FOX-2 Juice A 
 
✚ TBARS Juice A 
(P<0.05) 
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Buscemi et 
al. (2012) 
Randomize 
d 
Crossover 
Trial 
 
 
 
Neutral 
Groups: ROJ 
Intake, Placebo 
N: 19 
 
 
 
 
% Female: 47 
 
Age: 43±13 
 
years 
 
Juice: red 
orange juice 
 
 
 
Dose: 500ml/da 
y 
Duration: one 
week 
  
 
 
 
 
 
 
+ Protein carbonyls (NS) 
 
Freedman 
et al. 
(2001) 
 
 
 
Non- 
Controlled 
Trial 
 
 
 
Neutral 
Group: Treatmen 
t 
 
 
 
N: 20 
 
 
 
 
% Female: 40 
 
 
 
 
Age: 30 years 
 
(range 20 to 45 
years) 
 
Juice: purple 
grape 
 
 
 
 
 
Dose: 7ml/kg/da 
y 
 
 
 
Duration: two 
weeks 
 
 
 
 
 
 
 
+ ORAC 
 
✚ ORAC 
PCA (P<0.05) 
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Gorinstein 
et al. 
(2004) 
Randomize 
d 
Controlled 
Trial 
Neutral 
 
Groups: Control; 
100ml per day 
juice; 200ml per 
day juice 
N: 24 
 
% Female: NR 
 
Age: 43 to 71 
years (range) 
 
Juice: pumello- 
grapefruit 
hybrid 
("Sweetie") 
Dose: 100 or 
200ml per day 
Duration: 30 
days 
 
 
 
✚ TEAC 
 
100ml/day 
dose (P<0.05) 
✚ TEAC 
 
200ml/day 
dose (P<0.05) 
 
Inoue et al. 
(2008) 
Randomize 
d 
Controlled 
Trial 
Neutral 
 
 
Groups: Treatme 
nt 
N: 10 
 
% Female: 0 
 
Age: 37±8 years 
 
 
 
Juice: camu- 
camu 
Dose: 70ml/day 
Duration: 7 days 
 ✚ ROS (P<0.01), then 
 
returned to baseline 
 
✚ U 8-OHdG (Urine 8- 
hydroxy- 
deoxyguanosine): (P<0.0 
5), then returned to 
baseline 
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Karlsen et 
al. (2010) 
Randomize 
d 
Controlled 
Trial 
Positive 
 
 
 
 
 
Group: Treatmen 
t, control (water) 
N: 31 treatment; 
 
31 control 
 
% Female: 32 
 
Age: 53 years 
 
(range: 34 to 68 
years) 
 
 
 
 
 
 
 
 
Juice: bilberry 
 
Dose: 330ml/da 
y 
Duration: four 
weeks 
+ FRAP 
 
+ ORAC 
 
plasma 
 
 ORAC 
PCA 
 AA 
 
 TRAP 
 
+ Total 
glutathione 
+ Reduced 
glutathione 
 
 
 
 
 
 
 
 
 DHAA:TAA ratio 
 
+ D-ROM 
 
 Oxidized glutathione 
 
 Plasma glutathione 
redox potential 
Rowe et al. 
(2011) 
Randomize 
d 
Controlled 
Trial 
Positive 
Group: Treatmen 
t (grape), placebo 
N: 40 (grape), 38 
(placebo) 
% Female: 68 
 
Age: 58.7±6.1 
 
years (grape), 
 
Juice: grape 
(Concord) 
Dose: 360ml/da 
y 
Duration: nine 
weeks 
 
 
Treatment x 
time 
interaction 
✚ ORAC 
(P=0.01) 
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1Within arm change unless otherwise indicated, p value for at least one post-baseline 
measurement 
2Bold text = statistically significant finding  
 56.9±6.1 years 
(placebo) 
   
HFHC = High-fat, high-calorie meal; NR = Not reported; FRAP = ferric reducing ability of 
plasma; FOX-2 = ferrous oxidation of xylene orange; TBARS = thiobarbituric acid reactive 
substances; ORAC = oxygen radical absorbance capacity; ORAC PCA = perchloric acid; ROS- 
PMN/MNC = reactive oxygen species produced by polymorphonuclear leukocytes or 
mononuclear leukocytes; TEAC = total peroxyl-radical trapping activity; ROS = reactive oxygen 
species; U 8-OHdG = urinary 8-hydroxy-deoxyguanosine; AA = ascorbic acid; TRAP = total 
peroxyl-radical trapping activity; DHAA:TAA ratio = dehydroascorbic acid:total ascorbic acid 
ratio; D-ROM = diacrons reactive oxygen metabolites; DCHF = dichlorofluorescein 
fluorescence. 
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Table 2 Studies on blood lipid status and consumption of 100% fruit juice among adults 
 
 
Study Groups 100% Fruit Juice Type Outcomes1 
Design Final N  Changes in Outcomes2 
 
 
Quality 
 
 
Sex (% Female) 
 
 
Dose 
✚ improved significantly 
 
+ improved non- 
significantly 
 Age (mean±SD) Duration of Exposure  did not improve 
Aviram et al. 
(2000) 
Non- 
Controlled 
Trial 
Neutral 
Group: Treatment 
N: 13 
% Female: 0 
 
Age: 20 to 35 years 
(range) 
 
 
 
Juice: pomegranate 
Dose: 50ml/day 
Duration: 2 weeks 
 
 TC 
 
 LDL 
 
 HDL 
 
 TG 
Gorinstein et 
al. (2004) 
Randomized 
Controlled 
Trial 
Neutral 
Groups: control; 
100ml juice/day; 
200ml juice/day 
N: 24 
% Female: NR 
Age: 43 to 71 years 
Juice: pumello-grapefruit 
hybrid ("Sweetie") 
Dose: 100 or 200ml per 
day 
Duration: 30 days 
 
Comparison: treatment 
100 ml/day 
 
+ TC (NS) 
 
✚ LDL (P<0.01) 
 
✚ HDL (NS) 
 
✚ TG (NS) 
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 (range) groups versus control 200 ml/day 
 
✚ TC (P<0.01) 
 
✚ LDL (P<0.0005) 
 
+ HDL 
 
✚ TG (P<0.0005) 
 
Treatment groups compared 
to control post treatment 
 
 
 
 
Kurowska, et 
al. (2000) 
Non- 
Randomized 
Crossover 
Trial 
Positive 
 
 
 
 
 
Groups: dose groups 
of 250, 500, 750 
ml/day 
N: 75 
% Female: 36 
 
Age: 55±11 years 
 
 
 
 
 
 
 
Juice: orange 
 
Dose: 250, 500, 750 
 
ml/day 
 
Duration: 4 weeks 
250 ml/day 
 
 TC 
 
 LDL 
 
 HDL 
 
 TG 
500 ml/day 
 TC 
 
 LDL 
 
+ HDL 
 
 TG (NS) 
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   750 ml/day 
 
 TC 
 
 LDL 
 
✚ HDL (P<0.05) 
 
TG 
 
 
Mattei et al. 
(2012) 
Cross- 
Sectional 
Study 
Positive 
Groups: serving 
groups 
N: 1065 
 
% Female: 24 non- 
consumers, 27 daily 
consumers 
Age: 59.1±10.5 
 
years 
 
 
Juice: orange or other fruit 
 
Dose: never, ≤1 
serving/week, 2-6 
servings/week,≥1 
serving/day 
Duration: NA 
 
 
 
 
 
✚ HDL (P=0.033) 
 
 TG 
 
(P value for trend) 
O'Neil et al. 
(2012) 
Cross- 
Sectional 
Study 
Positive 
Groups: consumers, 
non-consumers 
N: 8861 
 
% Female: NR 
Age: NR 
 
 
Juice: orange 
 
Dose: non-consumers, 
consumers 
Duration: NA 
 
✚ TC (P=0.022) 
 
✚ LDL (P=0.011) 
 
 HDL 
 
+ TG 
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measurement 
 
2Bold text = statistically significant finding 
NR = Not reported; TC = total cholesterol; LDL = low-density lipoprotein cholesterol; HDL = 
high-density lipoprotein cholesterol; TG = triglycerides. 
1Within arm change unless otherwise indicated, p value for at least one post-baseline 
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Table 3. Characteristics Identified in the Examined Studies Affecting Antioxidant/Oxidant 
Status and Blood Lipid Outcomes 
 
Characteristic Studies 
Juice 
Specific Juice or juice mix Bub et al. (2003), Inoue et al. (2004), Ko et al. 
(2005), Snyder et al. (2011) 
Juice v supplement Inoue et al. (2004) 
Dose Kurowska et al. (2000), Gorinstein et al. 
(2004) 
Outcome Measurement 
Marker measured Freedman et al. (2001), Bub et al. (2003), 
Inoue et al. (2004), Ghanim et al. (2010), 
Karlsen et al. (2010), Rowe et al. (2011), 
Snyder et al. (2011), Buscemi et al. (2012) 
Timing of measurement Bub et al. (2003), Gorinstein et al. (2004), 
Inoue et al. (2004), Ko et al. (2005), Ghanim 
et al. (2010), Snyder et al. (2011) 
Target tissue Bub et al. (2003), Karlsen et al. (2010) 
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Subject Characteristics 
Baseline health risk (profile) of subject Inoue et al. (2004), Rowe et al. (2011), 
Buscemi et al. (2012) 
Age of subject Rowe et al. (2011) 
Genetic baseline Rowe et al. (2011) 
Behavioral Confounders 
Food consumed with juice Ghanim et al. (2010) 
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Figure 2 Search strategy flow diagram for research evaluating the relationship between blood 
lipid levels and 100% fruit juice consumption among adults 
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Figure 3 Study Characteristics Influencing Immediate Antioxidant/Oxidant Status or 
Downstream Health Effects Following Consumption of 100% Fruit Juice*. *Bold text indicates 
characteristics for which there is direct research in the studies examined. Normal text indicates 
characteristics indicated in other studies. 
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Appendix: Table of Study Quality Criteria Ratings 
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Yes = Criterion met, No = Criterion not met, ???=Unclear whether criterion met, N/A=Not 
applicable 
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